New drug approval: Nivolumab plus Ipilimumab/chemotherapy in esophageal squamous-cell carcinoma

被引：0
|
作者：
Chalah, Celine [1 ]
Neuzillet, Cindy [2 ]
机构：
[1] Hop St Antoine, Serv Gastroenterol, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Inst Curie Site St Cloud, 35 Rue Dailly, F-92210 St Cloud, France
来源：
BULLETIN DU CANCER | 2022年 / 109卷 / 10期
关键词：
Immune therapy; Anti-PD1; Anti-CTLA4; Esophageal cancer; CHEMOTHERAPY; JUNCTION; PLACEBO;
D O I：
10.1016/j.bulcan.2022.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：990 / 991
页数：2
相关论文
共 50 条
  • [11] Chemoimmunotherapy plus radiotherapy in advanced esophageal squamous-cell carcinoma
    Han, Xiang
    Zhang, Ling
    Hou, Qiuyu
    Ji, Youxin
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 437 - 437
  • [12] ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
    SERRA, LB
    BRITISH JOURNAL OF SURGERY, 1981, 68 (04) : 292 - 292
  • [13] The overall safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma.
    Shiraishi, Kazuhiro
    Yamamoto, Shun
    Yoshinami, Yuri
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kashiraha, Tairo
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Igaki, Hiroshi
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 329 - 329
  • [14] Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab
    Sudo, Kazuki
    Kato, Ken
    Matsuzaki, Juntaro
    Takizawa, Satoko
    Aoki, Yoshiaki
    Shoji, Hirokazu
    Iwasa, Satoru
    Honma, Yoshitaka
    Takashima, Atsuo
    Sakamoto, Hiromi
    Naka, Tomoaki
    Sekine, Shigeki
    Boku, Narikazu
    Ochiya, Takahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (02) : 114 - 121
  • [15] Nivolumab plus ipilimumab (NI) versus chemotherapy plus nivolumab (CN) in squamous cell lung cancer (SqCLC): The SQUINT trial
    Landi, L.
    Bonanno, L.
    Delmonte, A.
    Maximilian, P.
    Stati, V.
    Minotti, V.
    Bennati, C.
    D'Inca, F.
    Migliorino, M. R.
    Gori, S.
    Santo, A.
    Piantedosi, F.
    Russo, A.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [16] Nivolumab Plus Ipilimumab (NI) Versus Chemotherapy Plus Nivolumab (CN) in Squamous Cell Lung Cancer (SqCLC): The SQUINT Trial
    Landi, L.
    Bonanno, L.
    Delmonte, A.
    Papi, M.
    Stati, V.
    Minotti, V.
    Bennati, C.
    D'Inca, F.
    Migliorino, M.
    Gori, S.
    Santo, A.
    Piantedosi, F.
    Russo, A.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S727 - S727
  • [17] ESOPHAGEAL SQUAMOUS-CELL PAPILLOMA, SUSPECTED OF SQUAMOUS-CELL CARCINOMA
    YUKI, T
    KAWANO, S
    OGIHARA, T
    SATO, N
    OKAMOTO, S
    SATO, K
    KAMADA, T
    TAKADA, N
    FURUKAWA, J
    OKAMURA, J
    INTERNAL MEDICINE, 1993, 32 (10) : 773 - 776
  • [18] SURGERY FOR ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
    MILLAR, J
    LANCET, 1994, 343 (8905): : 1099 - 1099
  • [19] SQUAMOUS-CELL CARCINOMA IN AN ESOPHAGEAL POLYP
    PETRY, JJ
    SHAPSHAY, S
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1981, 107 (03) : 192 - 193
  • [20] Hypochlorhydria in esophageal squamous-cell carcinoma
    Iijima, Katsunori
    Koike, Tomoyuki
    Abe, Yasuhiko
    Yamagishi, Hatsushi
    Imatani, Akira
    Ohara, Shuichi
    Shimosegawa, Tooru
    GASTROENTEROLOGY, 2007, 132 (04) : A418 - A418
12345